Purchase Order SPE2DP24P0797
Award Date
9/26/24
Potential Completion Date
10/7/24
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
Med Stop Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77074, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DP25V0113, was issued by the Defense Logistics Agency's Medical Supply Chain to Med Stop Pharmaceuticals Inc., a SBA Certified Women-Owned Small Business. The $2,334.45 firm fixed-price purchase order is for the supply of Erythromycin tablets, with a completion date of October 25, 2024. The contract does not have a set-aside designation. Med Stop Pharmaceuticals Inc. is a minority-owned, economically disadvantaged women-owned small business that...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Med Stop Pharmaceuticals Inc., a Small Business Administration (SBA) Certified Women-Owned Small Business located in Houston, Texas. The contract, valued at $1,445.16, is for the supply of pharmaceutical products, primarily injectable medications, tablets, and medical solutions such as Erythromycin tablets, Adenosine injection, Cefoxitin for injection, Tetracaine hydrochloride,...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Med Stop Pharmaceuticals Inc., a Small Business Administration (SBA) Certified Women-Owned Small Business located in Houston, Texas. The contract has a ceiling value of $18,758.90 and an ultimate completion date of January 28, 2025. The contract is for the supply of various pharmaceutical products, including injectable medications, tablets, and medical solutions such as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,055.24, is for the delivery of Erythromycin Ophthalmic, a prescription medication, to support the medical supply needs of military health facilities. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Erythromycin Ophthalmic, a medical product, with a ceiling value of $1,695.75 and a period of performance through March 6, 2025. The contract is not set aside for any specific socioeconomic program. DMS Pharmaceutical Group Inc....
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract is for the delivery of Erythromycin Ophthalmic, a pharmaceutical product, with a ceiling value of $1,329.25 and a completion date of April 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at $499,999,999 and valid...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,326.31 firm fixed-price delivery order is for the supply of Erythromycin Ophthalmic, a prescription eye medication, to support the recurring medical needs of U.S. military health facilities. The award is associated with a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a $1,614.00 firm fixed price purchase order contract to Med Stop Pharmaceuticals Inc., a SBA Certified Women-Owned Small Business. The contract is for the supply of Adenosine Injection, a pharmaceutical product, with a completion date of July 1, 2024. The contract does not utilize any set-aside designations. Med Stop Pharmaceuticals Inc. is also classified as a Minority Owned Business, Self Certified Small Disadvantaged...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,786.44, is for the delivery of ERYTHROMYCIN OPHTHALM, a pharmaceutical product, with a completion date of August 17, 2023. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award, identified as SPE2DP24V1994, was issued by the Defense Logistics Agency's Medical Supply Chain to Med Stop Pharmaceuticals Inc., a U.S. Small Business Administration (SBA) certified Women-Owned Small Business (WOSB) located in Houston, Texas. The contract is for the supply of the pharmaceutical product prochlorperazine, with a firm fixed price of $1,798.90 and a completion date of August 6, 2024. The contract was awarded on July 23, 2024 and is not designated as a...